Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Change in Cash (2017 - 2025)

Historic Change in Cash for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$10.0 million.

  • Arcus Biosciences' Change in Cash fell 12222.22% to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.0 million, marking a year-over-year increase of 11764.71%. This contributed to the annual value of $23.0 million for FY2024, which is 12911.39% up from last year.
  • According to the latest figures from Q3 2025, Arcus Biosciences' Change in Cash is -$10.0 million, which was down 12222.22% from $56.0 million recorded in Q2 2025.
  • Arcus Biosciences' Change in Cash's 5-year high stood at $401.0 million during Q1 2022, with a 5-year trough of -$276.0 million in Q2 2022.
  • In the last 5 years, Arcus Biosciences' Change in Cash had a median value of -$12.0 million in 2022 and averaged $3.5 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 222857.6% in 2021, then tumbled by 37500.0% in 2023.
  • Over the past 5 years, Arcus Biosciences' Change in Cash (Quarter) stood at -$31.8 million in 2021, then skyrocketed by 62.29% to -$12.0 million in 2022, then crashed by 375.0% to -$57.0 million in 2023, then rose by 10.53% to -$51.0 million in 2024, then soared by 80.39% to -$10.0 million in 2025.
  • Its Change in Cash was -$10.0 million in Q3 2025, compared to $56.0 million in Q2 2025 and $42.0 million in Q1 2025.